X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 M | 2025-12-09 | FROPX | Flat Rock Opportunity Fund | Closed-End Funds | 3 | P - Purchase | $16.30 | +6,136 | 22,695 | +37% | +$100,000 | |||||
| 2 D | 2025-11-25 | DFDV | Defi Development Corp. | Finance Services | 2 | P - Purchase | $5.98 | +21,960 | 3,151,241 | +1% | +$131,278 | |||||
| 4 | 2025-12-11 | CDNL | Cardinal Infrastructure Group Inc. | Heavy Construction Non-Bldg Contractors | 4 | P - Purchase | $21.00 | +41,000 | 60,342 | +212% | +$861,000 | |||||
| 4 | 2025-12-08 | DOMH | Dominari Holdings Inc. | Security Brokers, Dealers & Flotation Companies | 2 | P - Purchase | $3.87 | +96,000 | 4,204,690 | +2% | +$371,704 | |||||
| 3 DM | 2025-12-08 | TENX | Tenax Therapeutics, Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $8.59 | +18,000 | 20,654 | +678% | +$154,579 | |||||
| 5 M | 2025-12-10 | GAM | General American Investors Co Inc | Closed-End Funds | 2 | P - Purchase | $24.99 | +77,325 | 1,853,236 | +4% | +$1,932,010 | |||||
| 20 M | 2025-12-08 | TPVG | Triplepoint Venture Growth Bdc Corp. | Closed-End Funds | 2 | P - Purchase | $6.30 | +1,562,180 | 3,282,975 | +91% | +$9,834,164 | |||||
| 2 | 2025-12-10 | JFB | Jfb Construction Holdings | Nonresidential Bldg Contractors | 2 | P - Purchase | $17.19 | +7,450 | 457,450 | +2% | +$128,077 | |||||
| 2 M | 2025-12-08 | VSTS | Vestis Corp | Miscellaneous Nondurable Goods | 2 | P - Purchase | $6.40 | +170,746 | 672,346 | +34% | +$1,092,046 | |||||
| 3 | 2025-11-17 | AVTR | Avantor, Inc. | Laboratory Analytical Instruments | 3 | P - Purchase | $11.16 | +537,500 | 999,641 | +116% | +$5,999,625 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-10 | SURG | Surgepays, Inc. | May David Allen | Dir | P - Purchase | $1.60 | +38,422 | 158,116 | +32% | +$61,647 | ||||||
2025-11-28 | CNTM | Connectm Technology Solutions, Inc. | Panigrahi Bhaskar | See Remarks | P - Purchase | $0.23 | +297,400 | 9,335,406 | +3% | +$67,478 | ||||||
2025-12-10 | LYFT | Lyft, Inc. | Risher John David | CEO | P - Purchase | $19.80 | +5,030 | 11,802,296 | 0% | +$99,617 | ||||||
2025-12-09 | FROPX | Flat Rock Opportunity Fund | Durston Marshall | Dir | P - Purchase | $16.31 | +1,533 | 3,661 | +72% | +$25,000 | ||||||
2025-12-09 | FROPX | Flat Rock Opportunity Fund | Coolidge R. Scott | Dir | P - Purchase | $16.31 | +1,533 | 3,661 | +72% | +$25,000 | ||||||
2025-12-09 | CORFX | Flat Rock Core Income Fund | Durston Marshall | Dir | P - Purchase | $19.81 | +1,262 | 3,063 | +70% | +$25,000 | ||||||
2025-12-09 | CORFX | Flat Rock Core Income Fund | Coolidge R. Scott | Dir | P - Purchase | $19.81 | +1,262 | 3,063 | +70% | +$25,000 | ||||||
2025-12-09 | CORFX | Flat Rock Core Income Fund | Finnen Paul E. | Dir | P - Purchase | $19.81 | +1,262 | 3,063 | +70% | +$25,000 | ||||||
2025-12-09 | FRBBX | Flat Rock Enhanced Income Fund | Durston Marshall | Dir | P - Purchase | $21.93 | +1,140 | 2,217 | +106% | +$25,000 | ||||||
2025-12-09 | FRBBX | Flat Rock Enhanced Income Fund | Coolidge R. Scott | Dir | P - Purchase | $21.93 | +1,140 | 2,217 | +106% | +$25,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-10 | SURG | Surgepays, Inc. | May David Allen | Dir | P - Purchase | $1.60 | +38,422 | 158,116 | +32% | +$61,647 | ||||||
2025-11-28 | CNTM | Connectm Technology Solutions, Inc. | Panigrahi Bhaskar | See Remarks | P - Purchase | $0.23 | +297,400 | 9,335,406 | +3% | +$67,478 | ||||||
2025-12-11 | NWPP | New Peoples Bankshares Inc | Keene Harold L | Dir, 10% | P - Purchase | $3.65 | +57,060 | 4,622,478 | +1% | +$208,269 | ||||||
2025-12-10 | NWPP | New Peoples Bankshares Inc | White Blaine Scott | Dir, 10% | P - Purchase | $3.65 | +101,500 | 5,835,456 | +2% | +$370,475 | ||||||
2025-12-10 | WEST | Westrock Coffee Co | Ford Scott T | CEO, 10% | P - Purchase | $4.14 | +100,000 | 23,769,505 | 0% | +$414,000 | ||||||
| M | 2025-12-09 | LSAK | Lesaka Technologies Inc | Smith Daniel Luke | Group CFO | P - Purchase | $4.34 | +17,264 | 250,500 | +7% | +$74,867 | |||||
2025-12-10 | FGBI | First Guaranty Bancshares, Inc. | Walker Robert W | Dir | P - Purchase | $4.54 | +7,500 | 45,376 | +20% | +$34,050 | ||||||
| DM | 2025-11-14 | SLSN | Solesence, Inc. | Whitmore R Janet | Dir | P - Purchase | $1.80 | +35,056 | 4,133,340 | +1% | +$63,274 | |||||
2025-12-09 | NRDY | Nerdy Inc. | Cohn Charles K. | CEO, 10% | P - Purchase | $1.44 | +176,215 | 57,231,904 | 0% | +$253,750 | ||||||
| D | 2025-12-10 | APRE | Aprea Therapeutics, Inc. | Duey Marc | Dir | P - Purchase | $1.17 | +21,459 | 256,757 | +9% | +$25,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-09 | PCRX | Pacira Biosciences, Inc. | Cross Shawn | CFO | S - Sale+OE | $25.07 | -25,000 | 56,250 | -31% | -$626,751 | |||||
2025-12-10 | ECPG | Encore Capital Group Inc | Bell Ryan B | Pres, MCM | S - Sale | $55.00 | -2,500 | 55,410 | -4% | -$137,500 | ||||||
2025-12-10 | IOT | Samsara Inc. | Phillips Dominic | See remarks | S - Sale | $44.46 | -8,231 | 1,737,010 | 0% | -$365,968 | ||||||
| D | 2025-12-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, Immunovant CEO | S - Sale+OE | $20.85 | -200,000 | 1,497,908 | -12% | -$4,170,000 | |||||
| M | 2025-12-09 | AL | Air Lease Corp | Udvar-Hazy Steven F | Dir | S - Sale | $63.97 | -122,800 | 1,616,266 | -7% | -$7,855,617 | |||||
| M | 2025-12-09 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $17.09 | -50,000 | 2,169,988 | -2% | -$854,323 | |||||
2025-12-10 | IOT | Samsara Inc. | Eltoukhy Adam | See remarks | S - Sale | $44.45 | -9,498 | 396,862 | -2% | -$422,219 | ||||||
2025-12-09 | CRWD | Crowdstrike Holdings, Inc. | Gandhi Sameer K | Dir | S - Sale | $527.51 | -1,879 | 4,687,729 | 0% | -$991,193 | ||||||
2025-12-11 | EWBC | East West Bancorp Inc | Shi Parker | COO | S - Sale | $115.03 | -8,844 | 14,950 | -37% | -$1,017,325 | ||||||
2025-12-09 | RDDT | Reddit, Inc. | Reynolds Michelle Marie | Chief Accounting Officer | S - Sale | $232.95 | -11,249 | 10,558 | -52% | -$2,620,449 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AD | 2025-12-09 | AURX | Nuo Therapeutics, Inc. | Mintz Paul | Dir | F - Tax | $2.20 | -9,091 | 108,294 | -8% | -$20,000 | |||||
| DM | 2025-12-09 | PCRX | Pacira Biosciences, Inc. | Cross Shawn | CFO | M - OptEx | $16.45 | +25,000 | 56,250 | +80% | +$411,250 | |||||
| DM | 2025-12-09 | PCRX | Pacira Biosciences, Inc. | Cross Shawn | CFO | S - Sale+OE | $25.07 | -25,000 | 56,250 | -31% | -$626,751 | |||||
2025-12-10 | SURG | Surgepays, Inc. | May David Allen | Dir | P - Purchase | $1.60 | +38,422 | 158,116 | +32% | +$61,647 | ||||||
2025-12-10 | ECPG | Encore Capital Group Inc | Bell Ryan B | Pres, MCM | S - Sale | $55.00 | -2,500 | 55,410 | -4% | -$137,500 | ||||||
2025-12-08 | ASPI | Asp Isotopes Inc. | Ainscow Robert | Interim CEO, COO | S - Sale | $6.20 | -8,438 | 1,546,255 | -1% | -$52,341 | ||||||
2025-12-10 | IOT | Samsara Inc. | Phillips Dominic | See remarks | S - Sale | $44.46 | -8,231 | 1,737,010 | 0% | -$365,968 | ||||||
2025-12-10 | IOT | Samsara Inc. | Kirchhoff Benjamin Louis | CHIEF ACCOUNTING OFFICER | S - Sale | $44.44 | -1,609 | 98,976 | -2% | -$71,509 | ||||||
| D | 2025-12-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, Immunovant CEO | M - OptEx | $3.85 | +200,000 | 1,497,908 | +15% | +$770,000 | |||||
| D | 2025-12-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, Immunovant CEO | S - Sale+OE | $20.85 | -200,000 | 1,497,908 | -12% | -$4,170,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |